Clinical Trial Update: Neoadjuvant Letrozole and Palbociclib in Patients With Stage II-IIIB Breast Cancer, HR+, HER2 - [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating neoadjuvant letrozole with palbociclib in stage II-IIIB HR+, HER2-negative breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Letrozole (letrozole)
• Palbociclib (palbociclib)

Snippet

Sponsor: MedSIR | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED